Results 111 to 120 of about 5,120 (192)

B cells enable autoreactive T cells to avoid suppression. [PDF]

Proc Natl Acad Sci U S A
Funsten M, de Pooter R, Varanasi V, Burrows M, Block K, Kuznetsov A, Serreze D, Huang H, Chervonsky A.   +8 more
europepmc   +1 more source

Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry. [PDF]

MAbs
Hecht E, Martin E, Liko I, Mahan A, Sahasrabuddhe A, Tajoddin NN, Campuzano IDG.   +6 more
europepmc   +1 more source

Pharmacological considerations for next-generation protein therapeutics in cardiovascular disease. [PDF]

J Pharmacol Exp Ther
Lin E, Momin N.
europepmc   +1 more source

Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies. [PDF]

Front Immunol
Püsküllüoğlu M, Pacholczak-Madej R.
europepmc   +1 more source

Programmable multispecific polybodys for T cell engagement and checkpoint modulation enhancing solid tumor immunotherapy

T cells are a key component of the immune system, and the engagement between T cells and tumor cells is the fundamental basis for their antitumor effects.
Xiang, Jiajia, Yuan, Pengcheng, Shao, Shiqun, Fan, Jiaqi, Zhang, Wei, Patra, Hirak K, Liu, Jiwei, Gray, Alex BC, Shen, Youqing, Zhou, Zhuxian, Tang, Jianbin, Xu, Haoran, Shi, Xueying, Hou, Yunteng, Slater, Nigel KH, Yang, Qizhang, Xiao, Bing   +16 more
core  

Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control. [PDF]

Cancer Rep (Hoboken)
Obeagu EI.
europepmc   +1 more source

Editorial: The role of epithelial-derived cytokines in airway disease. [PDF]

Front Allergy
Ortega H, Chung KF.
europepmc   +1 more source

From Unmet Medical Need to Drug Candidate: A Translational Therapeutic Development Roadmap Illustrated by Dual-Payload Antibody-Drug Conjugates. [PDF]

Biomolecules
Honda T, Zhu GD.
europepmc   +1 more source

Targeted dual selection to optimize transposon stable pool generation of multispecifics. [PDF]

MAbs
Johnston J, Tierson S, Xu Y, Mix K, Guo YJ, Zenger S, Reczek D, Hoffmann D, Hall B, Brophy V.   +9 more
europepmc   +1 more source

scFv-based biologics in diabetes: from therapeutic potential to clinical prospects. [PDF]

Front Immunol
Ge S, Wang L, Huang Y, Guo H, Wei F, Li P, Li S, Liu Q, Xu J, Xiao Y, Piress Dias AC, Ji L.   +11 more
europepmc   +1 more source